Use of Tralokinumab in a Hairdresser With Severe Chronic Hand Eczema and Occupational Allergic Contact Dermatitis

Related Experiment Video

Updated: Jun 25, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Gabriel Portero-Campillo1,2, Laura Ortiz-Granjo1,2, Fernando Navarro-Blanco1,2

  • 1Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Contact Dermatitis
|June 23, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
allergic contact dermatitiscase reporthairdresserhand eczematralokinumab

More Related Videos

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Related Experiment Videos

Last Updated: Jun 25, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...

Articles linked to this work by shared authors, journal, and citation graph.

Survival and toxicity profile of elderly melanoma patients treated with immune checkpoint inhibitors: a retrospective study from a tertiary care center.

Melanoma research·2026

Successful Treatment of Recalcitrant Eosinophilic Pustular Folliculitis with Dupilumab.

Sultan Qaboos University medical journal·2025

Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.

The Australasian journal of dermatology·2024

Sensitization to textile dyes in Spain: Epidemiological situation (2019-2022).

Contact dermatitis·2024

Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019-2021 epidemiological situation.

Contact dermatitis·2022

Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study.

Contact dermatitis·2021

Contact Allergy to Textile Dye Mix in Italy: A SIDAPA Multicentre Observational Study.

Contact dermatitis·2026

Stratum Corneum Biomarkers for Differentiating Irritant and Allergic Contact Dermatitis.

Contact dermatitis·2026

Characteristics and Outcomes of Patients With Negative Patch Test Results and Systematic Literature Review.

Contact dermatitis·2026

Gold Contact Sensitization, Clinical Characteristics and Associations With Autoimmune Disease: A Retrospective Cohort Study With Registry Linkage.

Contact dermatitis·2026

Patch Test Relevance and Systemic Exposure Pathways in Eczema Patterns Suspected of Systemic Contact Dermatitis.

Contact dermatitis·2026

High Frequency of Sensitisation to Decyl and Lauryl Glucoside in Routine Patch Testing in the Netherland.

Contact dermatitis·2026

Correlation of serum 25-Hydroxyvitamin D levels with total IgE and peripheral blood eosinophil counts in patients with atopic dermatitis.

Allergy and asthma proceedings·2026

Treatment-refractory chronic urticaria with neutrophilia and elevated inflammatory markers.

Allergy and asthma proceedings·2026

Atopic biologic use and recalled irritable bowel syndrome symptom severity: A hypothesis generating retrospective survey evaluation.

Allergy and asthma proceedings·2026

Association of type 2 diabetes, obesity, and metabolic syndrome with patient-reported response to aeroallergen subcutaneous immunotherapy: A real-world cross-sectional study.

Allergy and asthma proceedings·2026

Repeated imiquimod challenge as an experimental model of psoriasiform inflammation and re-exposure associated reactivation.

Zoological research·2026

IgE-Binding Components in Fungi and Parasites: From Infection Severity to Allergy and Allergy Protection: An EAACI Position Paper.

Allergy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us